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Survival after severe acute renal failure (ARF): The Johannesburg
Hospital experience 1975—1984. Seggie J, Hayward A, Mime FJ, Meyers
AM, University of Witwatersrand, Johannesburg, South Africa. From
the records of 290 patients who required hemodialysis (HD) for ARF in
the 10 year period 1975—84, an analysis was obtained of the epidemiol-
ogy of ARF in a large general hospital, and of the nature and number of
acute insults to the kidneys and their influence upon outcome. The
number of patients treated increased steadily to approximately 40
annually; in the first five year period patients were drawn predomi-
nantly from surgical disciplines, but increasingly ARF was seen to
complicate medical conditions. Mortality remained high (54% in surgi-
cal, 44% in medical and 33% in O&G patients), reflecting gravity of
illness in subjects in whom ARF supervened. Mortality correlated
strongly with sum of acute insults (hypotension, sepsis, aminoglycoside
overdose, radiocontrast medium, pigmenturia, severe jaundice) to the
kidneys. Mortality in the ICU setting matched that in the non-ICU
patient (50%) but was significantly increased in patients ventilated for
respiratory failure (58%) over that in patients not requiring respiratory
support (40%). Older age also prejudiced outcome. The mortality rate in
patients >50 yrs being 56% vs. 26% (<30 yrs) and 45% (30 to 50 yrs).
Conclusions. ARF developing in the critically injured or ill patient
contributes significantly to mortality. Efforts must be made to limit the
total number of acute insults to the kidneys with which mortality is
closely correlated.
Iron overload in chronic hemodialysis patients and the clinicopathologi.
cal sequelae thereof. Holland AM, Ford BM, Rossouw DJ, Renal Unit,
Department of Medicine, Tygerberg Hospital, University of Stel-
lenbosch, South Africa. Our aim was to search for clinical and patho-
logical correlates of transfusional iron overload in chronic hemodialysis
patients. Forty—three chronic hemodialysis patients underwent clinical
examination, electro- and echocardiography, radiologic skeletal survey
and biochemical testing in search of secondary hemochromatosis.
Seven patients underwent liver biopsies. Serum ferritin correlated with
the number of blood transfusions. Anephric patients were at risk for
multiple transfusions, mean 173 units (P < 0.0001). Gross iron deposi-
tion was evident in hepatocytes and reticuloendothelial cells in 5
patients with serum ferritin > 1000 mg/mI; lysosome disruption was
present without cirrhosis. Conclusions. The classical syndrome of
pigmentation, cardiomyopathy, arthropathy, and endocrinopathy asso-
ciated with hemochromatosis was not found. Hepatocellular damage at
ultrastructural level suggests that transfusional iron overload in
hemodialysis patients is not benign. Anephric patients are at risk; iron
chelation therapy may be indicated.
Citrate (Ci) and pyrophosphate (PPi) inhibitors in recurrent calcium
stone formers (RSF). Laminski NA, Russell V.!, Sonnekus MI, and
Meyers AM, Department of Medicine, University of Witwatersrand and
S.A.I.M.R., South Africa. Many substances in urine are known to
inhibit formation of urinary calculi. Ci retards crystal growth by
reducing urinary saturation of CaOx & CaPO4 by complexing to
calcium. PPi, a low molecular wt. polyanion, acts at low concentration
by adsorbing onto crystals and altering their growth and agglomeration.
This study aimed to measure Ci and PPi in the urine of controls (C)
and patients (P) with recurrent calcium—containing renal calculi in the
following categories: nil metabolic change (NMC), absorptive hyper-
calciuria (AHC), renal hypercalciuria (RHC) and hyperuncosuria (HU).
PPi was measured in fasting urines of 17 C and 118 F, using an enzyme
assay where NADPH produced is stoichiometric to PPi consumed. Ci
was measured in 24 hour urines of 16 C and 65 P using Boehringer—Man-












PPiICr 3.81 171b 141b 1.32c 119b
ap< 0.025
b P < 0.01
P <0.005
Hypocitraturia (<2.4 mmoll24 hrs) is common in all RSF with a
prevalence of 33 to 53%. If Ci/Cr ratios are determined, a further group
is unmasked which may have relative hypocitraturia. Low PPiICr ratios
(<1.0) are common in all RSF, except those with hyperparathyroidism
(HPT), with a prevalence of 45 to 75%. Increased PPi/Cr in HPT may be
an important additional diagnostic test, and a means of differentiating
them from other RSF. Thus with the additional measurement of urinary
Ci & PPi, the % of P with an original diagnosis of NMC decreased from
30 to 7.4%.
T cell subsets in renal transplant biopsy material. A prognostic
indicator? Pascoe MD, Temple-Camp C, Swanepoel CR, Cassidy MJD,
van Zyl-Smit R, and Jacobson JE. Departments of Medicine, Pathol-
ogy and Surgery, University of Cape Town and Renal Unit, Groote
Schuur Hospital, South Africa. It has been suggested in the literature
that an assessment of lymphocyte subtypes in renal transplant biopsy
material is a useful prognostic indicator; there are many contradictory
reports. Renal transplants biopsies (Bx) were performed for clinical
indications. Immediate frozen section examination was followed by
careful evaluation of the lymphocyte subsets in the worst perivascular
and interestitial areas. The lymphocytes were identified by the use of
monoclonal antibodies using a peroxidase anti-peroxidase technique.
The total cell count for each subtype was counted in an area of 0.142
mm2. Biopsies done within 30 days of renal allografting were evaluated,
and grafts which never functioned were excluded from analysis. Four-
teen biopsies were available for evaluation. The creatinine clearance at
eight weeks post-Bx was used to evaluate graft outcome. Total lym-
phocytes, OKT 4/8 ratio OKT4, OKT8, Pan B and inactive cells in
neither the perivascular or the interstial, nor both areas correlated with
graft outcome. The overall pathological assessment of the degree of
severity of the rejection process was a better but not strong prognostic
tool.
Comparative physiology of renal tubular transport processes. Nicolson
SW and Isaacson LC, Departments of Zoology & Physiology, Univer-
sity of Cape Town, Cape Town, South Africa. We have conducted
preliminary studies on Malpighian tubules of a Namib Desert beetle,
Onymacrisplana, and on renal tubules of the Nile crocodile, Crocodilus
niloticus. The beetle has six morphologically and electrically identical
Malpighian tubules, about 8 cm long. The transtubular potential (13.3
2.3 mY, lumen positive mean SE, N = 36) and basal membrane
potential (—31.2 0.6 mV, N = 108) are constant along each tubule.
The basolateral membrane is 2.5 x more permeable to K than Cl, but
impermeable to Na. Beetle diuretic hormone promotes water, K and Na
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excretion, with rapid transtubular depolarization to near zero, cAMP
effects are similar, but with slow hyperpolarisation (to 60 5 mV).
Basal potentials are not affected by either stimulant. Microdisseetion of
two crocodile kidneys showed that well developed glomeruli are
confined to a zone midway between the capsule and the lobule surface.
Proximal tubules ascend directly to the surface, making a hairpin bend,
and then descend in close opposition towards the medulla. The mor-
phology is that of a countercurrent mechanism; yet the urine is always
hyposmotic. Tubules from both these species are now being isolated
and perfused in vitro. These preparations offer alternate means of
testing hypotheses of renal tubular transport mechanisms in mammalian
systems.
Swan—Ganz catheterization, fluid loading and the incidence of renal
failure following aortic reconstruction. Hesdorffer CS, Mime FJ, Meyers
AM, Clinton C, Botha R, Departments of Medicine (Nephrology) and
Surgery, Johannesburg Hospital and the University of the
Witwatersrand, Johannesburg, South Africa. The purpose of this study
was to determine to what extent accurate volume loading of patients
undergoing abdominal aneurysmectomy reduced the incidence of acute
renal failure and thus the overall outcome of this operative procedure.
The analysis was a prospective one comparing 61 patients with 87
historical controls. During the original study, volume replacement was
very haphazard with monitoring being dependent on blood pressure,
urine output and the central venous pressure. The 61 patients in the
prospective analysis had Swan—Ganz catheters inserted 24 hours prior
to elective surgery. Fluids were thus titrated to the level of the
pulmonary artery wedge pressure. The incidence of hypotensive epi-
sodes dropped significantly from 31 out of 62 patients during the original
study to 13 out of 44 patients following the introduction of routine
Swan-.Ganz catheterization (P < 0.03). Renal failure occurred in only
10% of patients compared with 33% in the controls (P < 0.001). The
decreased incidence of renal failure accounts for the reduction in
mortality noted (P < 0.01). There were 27 deaths (3 1%) among the
patients in the earlier study compared with nine (15%) in the prospec-
tive analysis. These significantly improved results indicate the value of
invasive pressure monitoring and volume loading in patients undergoing
abdominal aortic surgery.
Hemodialysis access with subclavian catheters—.experience at Groote
Schuur Hospital. Tribe R, Williams M, Swanepoel CR, Department of
Medicine, University of Cape Town and Renal Unit, Groote Schuur
Hospital, Cape Town, South Africa. This is a prospective study to
document the use and complications of subclavian venous catheters in
hemodialysis. Patients with acute or chronic renal failure were studied.
Single and double lumen catheters were used. These catheters were
inserted by a standard technique. The complications were noted. Two
hundred and eighteen insertions were undertaken over nearly two
years. Failure to gain access was recorded in nine patients, Seven
double lumen catheters were used; none functioned adequately. Imme-
diate complications were: 14 (6.4%) malpositioned, two (1%)
pneumothoraces, 28 (12.8%) bleeding or hemotomas, 4 (2%) arterial
punctures. Late complications were: 31 (14%) infections (seven
septicemias and 24 localized), 16 (7%) clotted, 15 (6.8%) poor flow, 18
(8%) pulled Out or broken accidently, one pulmonary embolus. The
mean dwell time was 19.5 days (range 1 to 107 days) while the mean
dwell time of infected catheters was 40.6 days. The use of subelavian
catheters by experienced operators has a low morbidity and mortality.
No deaths in our series were attributable to the subclavian catheter.
The morbidity was mainly due to infections, mainly staphylococcal.
Infections were associated with longer than average use.
Aluminium excretion by the pig kidney. Monteagudo FSE, Isaacson
LC, Wilson G, Hickman R, Folb P1, Department of Pharmacology,
University of Cape Town, Cape Town, South Africa. Aluminium
loading has been shown to have serious clinical consequences. These
include dialysis eneephalopathy and osteodystrophy. It has been shown
that the kidney is the major organ of aluminium excretion, yet very little
information exists about the mechanisms by which the kidney excretes
this substance. We have used the "stop-flow" method of Malvin to
investigate the tubular handling of aluminium. The levels of aluminium
were measured using Graphite Furnace Atomic Absorption Spectros-
copy. Using these two techniques, we have determined the concentra-
tion of aluminium (and other substances) at various points along the pig
nephron. The levels of aluminium were significantly higher in the distal
compared with the proximal nephron. This implies an excretory mech-
anisni for aluminium at the distal nephron. Functionally, the proposed
aluminium excretion site is situated near the calcium and sodium
reabsorption sites in the distal nephron.
Membranous nephropathy in childhood, Wiggelinkhuizen J,
Sinclair—Smith C, Department of Paediatrics, University o.f Cape
Iowa, Cape Town, South Africa. The incidence of membranous
nephropathy (MGN) among 388 nephrotic children under the age of 13
years was 16.2%. The mean age at onset was six years, the male:female
ratio 4:25, and all were non-Caucasian. The clinical features were a
mild but indolent ncphrotie syndrome, hematuria (79%), transient mild
renal failure (29%), and hypertension at onset (3%) or during the course
of the disease (12.6%). Etiologic or associated factors were documented
in 84%: hepatitis B infection 73%; congenital syphilis 6%; lupus
erythematosus; d-penicillamine and Salmonella infective endocarditis
each 1.6%. Sixty—eight percent were in remission after an average
follow—up of 4.5 years. Average duration of the nephrotic syndrome
was 20 months; mean time to remission 30 months. Only two patients
(3%) had persistent renal failure, one of whom with syphilitic membra-
nous nephropathy, died 15 years after onset. Seven biopsies were
staged grade I, 34 grade 11, 20 grade III and 2 grade IV MGN. The
earlier the stage, the more likely and earlier remission occurred.
Immunosuppressive therapy in 15 cases was ineffective. The high
incidence of membranous nephropathy in non-Caucasian SA children is
related to the high prevalence of the hepatitis B carrier state in the
affected population groups. The outcome at five years is good, but
longer follow—up is needed to determine ultimate prognosis.
Minimal change glomerulopathy (MCG): A retrospective study of 40
patients over a 16 year period. Arnold S, Meyers AM, Seggie J,
Thomson PD, Ninin D, Departments of Medicine, Paediatric,s', and
Pathology, Johannesburg Hospital and SAIMR, Johannesburg, South
Africa. Prevalence, clinical features., associated diseases, response to
therapy and outcome were studied retrospectively in three groups of
Caucasians with documented MCG. Group 1: a widely selected group of
steroid resistant/dependent referred ex-pediatric patients >16 years of
age (N 14), Groups II & TIT: unselected adult—onset MCG ages 17 to
49 and >50 years, respectively (N 26). Ninety—five percent had renal
biopsies; prevalence of MCG in biopsied adult nephrotics = 26/147
(18%). 'l'reatment was steroids with or without other immunosuppres-
sants; 7 (27%) Groups II & III patients required no therapy.
Hypertension Hematuria (%) Renal R Response
Group M:F (%) (95) Failure 95
Associated diseases found in 11/40 (28%) or 9/16 (56%) Groups II & 111
patients, viz: Ulcerative Colitis 4, asthma 2, rheumatic fever, myasthe-
nia gravis, psoriasis, epilepsy and atrial myxoma 1 each; 2 patients
developed myocardial infarction and I deep venous thrombosis. Major
complications of R: CA breast I, pneumocystis C+MV (died), pulmo-
nary edema (died), & 1 coincidental death. Mortality 10%; 2 (50%)
from Group III. Conclusion: (i) prevalence of 17% of biopsied NS
similar to other reported studies; (ii) MCG occurs all across all age
ranges; (iii) other major disorders were commonly found; (iv) adults
respond as well as children but have more serious complications; (v) 1/4
adult patients reversed spontaneously; (vi) in steroid responsive adults,
alternate day regimen produced excellent responses.
The value of fiberoptic bronchoscopy in evaluating pulmonary shadows
in renal transplant recipients. Willcox PA, Bateman ED, Potgieter PD,
Renatar SR, Respiratory Clinic, Groote Schuur Hospital and Univer-
sity qf Cape Town, Cape Town, South Africa. Pulmonary infections are
a major cause of morbidity and mortality in renal transplant recipients.
In order to evaluate the role of fiberoptic bronchoscope in the evalua-








our prospectively documented experience over an 8½ year period.
Between January 1977 and August 1985, 41 bronchoscopies were
performed in 38 patients. A specific diagnosis was made in 22 (54%)
bronchoscopies. In three (7%), the procedure failed and in 16 (39%) no
specific diagnosis was made. Of these, 10 resolved on antibiotics,
pneumonia was found at autopsy in three (but no specific organism was
identified), two cleared spontaneously, and in a further case fibrosis was
found at autopsy. In 49% of procedures (20/4 1) the bronchoscopy was
considered to have brought about a change in management, but in only
34% (14/41) was it considered to have influenced survival. Bronchial
brushings gave a specific diagnosis in 18/41 procedures (44%) and
transbronchial biopsies in 11/23 procedures (48%), although biopsies
only contributed to establishing the diagnosis in 5/il cases. The
complication rate was low, with no significant hemorrhage and only one
pneumothorax which did not require drainage. Fiberoptic bronchos-
copy is a useful technique in evaluating pulmonary shadows in renal
transplant recipients.
Clinical course and renal histological data in systemic lupus
erythematosus (SLE). Cohen JD, Murray J, Ninin D, Mime FJ, Coro-
nation Hospital, University of the Witwatersrand Medical School and
SAIMR, Johannesburg, South Africa. We studied the clinical data and
renal histology in 17 patients (14 females and three males), all of whom
satisfied ARA criteria for SLE and who had all undergone at least two
renal biopsies. The group comprised 7 Blacks, 8 Asians and 2 Whites.
The mean interval between renal biopsies was 48 months (range II to 74
months). Renal biopsies were evaluated by light microscopy and
immunofluorescence, and each biopsy assigned an activity and sclerosis
index, as well as WHO class. Class II b was the most common lesion
noted on initial biopsy. On repeat biopsies, 13 of 17 patients underwent
a change in renal histology which occurred irrespective of initial class.
Class I and V lesions ran an unchanged course. Changes were always
toward more proliferative lesions. Seven patients had CRF (creat. >
180 mol/liter, mean 433 mol/liter) at time of repeat biopsy. These
patients were younger than the group with normal renal function at
second biopsy (20.5 10.0 vs. 25.2 9.3) and had a higher initial
activity index (5.2 4.0 vs. 0.8 1.0P = 0.006). No difference in initial
serum creatinine, degree of proteinuria, number of ARA criteria or
sclerosis index was noted between the two groups. Of note was the fact
that all the patients progressing to CRF had a class VI lesion at repeat
biopsy.
Nephrotoxic potential of iopamidol. Furman KI, and Harmse L,
Department of Experimental and Clinical Pharmacology, University of
the Witwatersrand, Johannesburg, South Africa. lopamidol is a non-
ionizing contrast agent that has a much lower osmolality (670 mOsm/kg
H20) than conventional ionizing monomers of equivalent iodine con-
centration (1500 mOsm/kg H20 for meglumine iothalamate). There is
unequivocal evidence that patients suffer less discomfort, such as pain
and heat, with iopamidol, however much of the available literature is
contradictory in regard to its nephrotoxic potential. The urinary excre-
tion of N-acetyl glucosamidase (NAG), y-gluteryl transferase (yGT)
and Beta2-microglobulin (B2M) was estimated in ten patients immedi-
ately prior to, and repeated 24 hours after radiological examination with
iopamidol. The findings were compared to those of ten patients who
were examined with meglumine iothalamate and investigated similarly.
All patients showed a significant increase in the urinary y-GT post
examination. Nine of the iopamidol and eight of the meglumine
iothalaniate group had in addition increased NAG and B2M excretion at
24 hours. There was no significant difference in the results of the two
groups of patients, indicating similar nephrotoxicity as far as can be
determined by these early markers of renal damage.
Should there be an alternative to the Tenckoff catheter? Parsoo I,
Naicker 5, Seedat YK, Renal Unit, Addington Hospital and Depart-
ment of Medicine, University of Natal, Durban, South Africa. Perito-
neal dialysis (PD.) was achieved successfully by Boen in 1962. A
permanent peritoneal catheter was developed by Henry Tenckhoff in
1968. Despite many modifications, it is the catheter of choice for
continuous peritoneal dialysis since the first description by Moncrief
and Popovich in 1975. The aim is to describe the technique of catheter
insertion as practiced in our unit. A double cuff Tenckoff was used, The
short and long term complications were evaluated. The study was from
January 1981 to November 1985 and 155 catheters were inserted into
125 patients. Skin exit infections occurred in 57 patients (45.6%); tract
abscesses in 22 patients (17.6%); immediate P.D. leak in six patients
(4.8%); one way obstruction in two patients; catheter displacement in
two patients and incisional hernia in four patients. There were no
anaesthetic complications. The technical complications associated with
the insertion are small with this method of insertion. Exit site infections
has decreased from 14 in 1984 to three in 1985.
Opsonic deficiency of peritoneal dialysis effluent in continuous ambu-
latory peritoneal dialysis (CAPD). Parsoo I, Seedat YK, Parag KB,
Renal Unit, Addington Hospital and Department of Medicine, Univer-
sity of Natal, Durban, South Africa. Peritonitis is a frequent complica-
tion of CAPD. An opsonic deficiency may be important in the patho-
genesis of peritonitis. This study evaluates the opsonic activity of the
peritoneal cavity after a rest period of eight hours. Eighteen patients
were evaluated. The duration of CAPD ranged from three to 31 months.
The concentration of IgG and C3 in the serum and peritoneal dialysis
effluent (PDE) were determined by nephelometry (Behring laser
nephlometer). Complement levels in the PDE ranged between <0.5 and
1.180 mg/dl (mean < 0.5). After an overnight rest period it ranged
between 1.812 and 10.5 (mean 3.035). The IgG levels showed a
respective rise from a mean of 3.101 mg/dI (1.989 to 16.82) to a mean of
120.3 (23.62 to 279.2). Serum levels of C3 and IgG were normal. The
opsonic activity of PDE increased after a rest period of eight hours. If
bacteria enter the peritoneal cavity there is an increased ability of the
phagocytic macrophages to destroy them effectively. Thus patients who
develop frequent bouts of peritonitis should be allowed a long
dialysis—free period to increase their opsonic activity.
Sodium hypochlorite vs. povidone.-.iodine for CAPD. Furman K!,
Doehring RO, Kleiman MS, and Rudnick J, Departments of Pharma-
cology and Microbiology, University of Witwatersrand, Johannesburg,
South Africa. Most CAPD centres favor the use of povidone—iodine
(PV-I) to ensure sterility during transfer set and dialysate bag change
procedures. It has been suggested by the proponents of the Perugia
system that 0.3% sodium hypochlorite (NaOCI) might be more suitable.
An in vitro study compared the antimicrobial efficacy of 0.3% NaOCl,
10% PV-I and 1/10 freshly diluted stock 10% PV-I with exposures up to
five minutes. This revealed equally rapid bactericidal action by the
NaOC1 and PV-I solutions against Staph. aureus, E. coli and Ps.
aeruginosa, with equally poor efficacy against B. subtilis spores. Both
the 10% PV-I and NaOCl had practically no effect against M. cheloni,
while the 1/10 PV-I had a complete kill by five minutes. The diluted
PV-I was also more rapidly fungicidal against C. albicans. Despite the
in vitro superior efficacy of freshly diluted 1/10 stock 10% PV-I solution,
NaOCl has been safely substituted for PV-I in clinical use at the
Johannesburg Hospital to suit individual patient preference.
The effects of beta blockade on renal function in patients with chronic
renal failure and hypertension. Furman KI, Meyers AM, Lustig A,
Departments of Pharmacology and Medicine, University of the
Witwatersrand, Johannesburg, South Africa. The consensus of numer-
ous studies in the literature on the effects of beta blockade on renal
excretory function is that only minor changes occur in patients whose
function is initially normal. The effects on renal function of patients
suffering from chronic renal failure has been less clearly defined. In a
double—blind crossover trial, the effects of atenolol (ATNL) and
acebutolol (ACBL) on renal function were determined in 16 hyperten-
sive patients with stable glomerular filtration rates (GFR) <50 mI/mm.
The most consistent finding with effective levels of both drugs was a
significant (P <0.05) decrease in 51CrEDTA clearance (—18.3 13.4%
for ATNL and —19.3 9.7% for ACBL), associated in the majority of
patients with an increase in renal blood flow (17.3 26.8% for ATNL
and 23.5 50.5% for ACBL), and a fall in renal vascular resistance
(—19.2 28.2% for ATNL and —19.5 31.8% for ACBL). Efferent
arteriolar dilatation following inhibition of renin release is considered to
be the most likely mechanism underlying these observations. A rather
marked fall in the GFR of three of these patients that had severe renal
failure (<15 ml/min) indicates that caution is necessary with the use of
beta blockers in this latter type of patient.
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An assessment of the quality of life on a chronic renal program (CRP)
In Natal. Seedat YK, Mcintosh CG, Subban JV, Renal Unit, Addington
Hospital and Department of Medicine, Universily of Natal, Durhan,
South Africa. We studied the group of patients currently on the CRP in
Natal with the aim of assessing the relative success of the different
treatment modalities in achieving patient rehabilitation regarding em-
ployment and their social, psychological and medical status. One
hundred and twenty—eight patients were assessed: 53 (41.4%) were on
continuous ambulatory peritoneal dialysis, 46 (35.9%) had functioning
renal transplants. 26 (20.3%) were on in-center hemodialysis (ICHD)
and three (2.3%) were on home dialysis. Sixty—six percent of patients
on CAPD were able to work compared with 80.8% on ICI-ID and 91.3%
of transplant recipients. Unemployment had risen in the whole popu-
lation group from 3.1% prior to the development of CRP to 21.9%. This
rise occurred in all three main treatment groups (34.6% unemployed for
ICHD, 18.9% for CAPD and 19.6% for the transplant group). Depres-
sion showed the highest prevalence in the ICHD group (50%) compared
the CAPD group (30.2%) and the transplant group (23.9%), (ICHD vs.
transplant group, P 0.024), There was a marked decrease in satisfac-
tion with sex life in the 2 main groups compared to the transplant
recipients (P = 0.003). The need for and length of hospitalization was
highest among CAPD patients and least following transplantation (P <
0.001). This study shows that provided stringent criteria are taken in
determining suitability of acceptance for C.R.P. quality of life is
improved and the best results are obtained with renal transplantation.
Colchicine reduces proteinuria in passive Heymann nephritis (PHN).
Milner LS, de Chaderevian JP, Goodyer PR, Fang JCS, Kaplan BS,
Department of Nephrology, Montreal Children's Hospital McGill Uni-
versity, Montreal, Canada. PHN is an analogue of human menibranous
nephropathy. Coichicine, (C) an anti-inflammatory was given to rats
with PHN to see if proteinuria could be reduced. Rats with PHN were
randomized into control (saline, 1 mI/d) or C treatment groups. Urine
protein excretion was significantly reduced by C (0.06 mg/day) after 14
days (89 18 vs. 270 72mg/day; P <0.05), 21 days (90 27 vs. 220
55 mg/day, 0.05), and 28 days (92 38 vs. 185 53 mg/days; P <
0.05). After 14 days urine albumin was significantly reduced in C treated
rats compared to controls (54 30 vs. 200 38 mg/d; P < 0.02), as well
as the albumin: creatinine ratio (8 3.8 vs. 29.6; P < 0.02). After 14
days rats receiving C - indomethacin (I) had similar urine protein
excretion compared to controls (144 43 vs. 249 86mg/day) but was
reduced in rats receiving C alone (73 14 vs. 249 86 mg/day, P <
0.05). The urine albumin; creatinine ratio was reduced in rats receiving
Calone(1.9 0.4vs. S l.9)butelevatedinratsreceivingC + 1(10.4
2.4 vs. 5.0 1.9). Serum cholesterol was significantly reduced in C
alone (69 16 vs. 132 92 mg/dl, P < 0.05) but was similar in rats
receiving C + 1 compared to controls (95 32 vs. 298 64 mg/dl).
Serum Trigs were also reduced in C alone (139 50 vs. 298 6 mg/dl,
P < 0.02), but were similar in rats receiving C + 1(205 23 vs. 298
64). No differences were seen in Serum C3 and renal C3 deposition after
14 days. These studies suggests that C reduces proteinuria in PHN,
which may be prostaglandin mediated.
Prevention by DMSO of glomerular injury in NZB/WF1 lupus mice.
Milner LS, Kaplan BS, Mills M, de Chadervian JI', Goodyer PR, Fang
JSC, Department Nephrology, Montreal Children '.v Hospital, McGill
University, Montreal, Canada. Dimethyl sulfoxide (DMSO), or
colchicine (C) was given to NZB/WF1 lupus mice to see if proteinuria
could be prevented in this model of glomerular injury. Twenty mice
were randomized into saline (0.1 mI/day) and DMSO (4 mg/g/day) or
saline (0.1 mi/day) and C (10 pg/day) treatment groups. A significant
reduction in urine protein excretion occurred in DMSO treated mice at
five and six months. By seven and 7.5 months the proteinuria was
similar in both groups. The urine protein: creatinine ratio was signifi-
cantly reduced in DMSO treated mice compared to controls at 6.5
months (DMSO: 13.4 1.3 vs. 24.4 4.2; P < 0.05), at seven months
(DMSO: 46.7 23 vs. 101 28; P < 0.05) and at 7.5 months (DMSO:
37 -t 13 vs. 88 31; P < (1.05). Serum TgG and ANA titers were similar
in both groups. Serum creatinine was significantly lower in DMSO
treated mice (0.41 0.08 mg/dl) compared to controls (0.91 0.56
mg/dl; P < 0.05). By 7.5 months of age, five of six treated mice had
relatively normal renal histology and six of eight untreated had severe
glomerular injury. The mice receiving C had significantly reduced urine
protein excretion at live months of age only compared to controls (6.69
0.65 vs. 10.7 0.54 mg/day; P < 0.05). No differences in serum
creatinine, C3, lgG levels and ANA titers occurred between controls
and C treated mice had severe glomerulonephritis. These studies
suggest that DMSO administration to NZB/WF1 lupus mice ameliorates
their glomerular injury.
Functional effects of diltiazem (DT) on the isolated perfused rat kidney
model (IRK). Meyers AM, Laminski N, Seymour RA, Department of
Medicine, University of Witwatersrand, Johannesburg, South Africa.
Although based on sound theory, scant experimental or clinical evi-
dence exists confirming that calcium channel antagonists improve the
course of acute vasomotor nephropathy (AVN). We therefore perfused
the IRK with Krebs solution (KS) containing 1.6 M mol/liter ionized
Ca. Group 1: controls = 6; experiment 6 that is, 100 ng/ml DT
added to KS. Group 2: Controls = 11; Experiment 9 that is, 50 /Lg/ml
DT to KS; "high dose". Group 3: Experiment=3 ISO zg/mi DT to KS;
"toxic dose". Urine and KS collected every 10 minutes for three hours.
Measurements: Uv, C14 inulin GFR, %TR of Na, K and Ca. Duration of
effective function was calculated. Pooled data expressed as mean
5EM; non-paired 1-tests for significant difl'erence. GFR: prolonged in
Group I & 2 DT kidneys (P < 0.05 and < 0.01 at 90' and 180',
respectively). %TR Na: Group I, control vs. DT, NS; Group 2, DT
kidneys intense natriuresis and diuresis at 30' and 80' (P < 0.05 and
<0.025). %TR Ca: marked calciuresis in Group 1; not tested in Group
2. Rapid death of IPK in Group 3 "toxic group". Conclusions: DT may
prolong GFR in IRK and thus modify AVN. The mechanisms require
further study, but may act by producing calciuresis and or natriuresis in
high doses. There was rapid anuria in toxic doses, possibly due to
afferent arteriolar spasm.
Use of triple therapy (TT) in cadaveric renal graft recipients.
Margolius LP, Meyers AM, Seggie JL, Botha JR, Department of
Medicine and Surgery, Johannesburg Hospital, Johannesburg, South
Africa. The feasibility, potential benefits and safety of'fl (cyclosporin,
azathioprine and prednisoline) was studied in 40 cadaveric renal graft
recipients. Indications were (i) denovo initiation of TT from the time of
transplantation for prolonged graft ischemia, ATN and grafts from
young donors (Group I), and (ii) chronic poor graft function resistant to
conventional anti-rejection therapy (Group II). Results: Group I. (N
8) Mean duration of IT was 1.9 (± 1.7) months, Six of eight had
functioning grafts and two of eight had rejected by the end of the study
period. Mean serum creatinine improved from 857 (±420) to 270 (± 127)
smo1/liter. (P < 0.01). Group II. (N = 32). Mean duration of conven-
tional therapy prior to TT was five months (10 days to 23 months). Mean
duration of TT was 5.2 (± 3.3) months. Twenty—four of 32 had function-
ing grafts and seven of 32 had rejected by the end of the study period.
One patient died. Mean serum creatinine improved from 302 (±207) to
183 (±80) mol/liter. (P < (1.05). The prevalence and mortality of major
infections were 8.1% and 2.7% respectively on TT versus 30% and 4%
on cyclosporine and prednisolone alone. Conclusion.c: TT may be
successfully used in recipients with prolonged graft ischemia and may
control chronic rejection in those with poor function, infective compli-
cations do not appear to be more common.
The effect of indapamide on serum and red cell cations in mild
hypertension. Taylor DR, Sonnekus Mi, Milne FJ, Hypertension Clinic
and Department of Medicine, Johannesburg Hospital, Johannesburg,
South Africa. Unlike many diuretics, Indapamide (I) does not cause
urinary Mg loss in normal subjects. We studied the effect of 1(2.5 mg)
on serum (5) and red cell (RBC) Na, K and Mg in elderly (mean
age 61.7 years) mild hypertension (BP 162/97) patients. After a six
week washout period, 27 patients completed a double—blind random
allocation to I (N IS) or placebo (P, N 12) for 16 weeks. After eight
weeks of I or P, Slow Mag, 6 tabs daily (3.2 gm) was added for the
remaining eight weeks to each group. Cations were measured at 0.8 and
16 weeks.
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Results in mmol/liter; mean SEM P < 0.05
0 8 16
SMg + P (N = 10) 0.81 0.02 0.83 0.02 0.90 0.03
I (N = 14) 0.82 0.02 0.83 0.02 0.90 0.03
RBC Mg P (N = 11) 2.48 0.09 2.21 0.09 2.46 0.12
I (N = 15) 2.49 0.10 2.32 0.08 2.59 0.09k
RBC Na P (N = 10) 8.46 0.45 8.65 0.48 9.77 0.84
I (N = 15) 8.35 0.31 10.02 0.55a 11.43 0.56
SK I (N = 15) 3.71 0.01 3.32 0.lla 3.57 0.10
I alone produced a significant fall in BP, but Slow Mag had no additional
effect on BP in either group. Slow Mag produced a significant rise in
RBC Mg from eight to 16 weeks in the I group. There was a
significant rise in RBC Na on indapamide alone. I caused a significant
fall in serum K but not in RBC Kt Thus, in elderly mild
hypertensives, indapamide does not affect serum or RBC Mg con-
centrations, either alone or after a Mg load, but produces a rise in
RBC Na as a result of the fall in serum Kt
The course of patients with end—stage renal failure due to lupus
nepbritis on dialysis. Kark A, Cohen J, Mime FJ, Veriava Y, Goldberg
B, Department of Medicine, JG StrUdom and Coronation Hospital and
University of the Witwatersrand, Johannesburg, South Africa. This is a
retrospective study of all patients with end—stage renal failure due to
lupus nephritis, and requiring maintenance hemodialysis for at least
three months in two dialysis units. Of the 11 patients three were male
and eight female with a mean age of 25 years and six months. Five were
Black and six White. Initial kidney biopsy showed WHO type IV in six
patients, III in four and V in one. Repeat biopsies were done in seven
patients showing marked progressive sclerosis in all. Four patients
progressed from a normal serum creatinine to end—stage renal failure in
less than five months, while in another four the progression was longer
than 18 months. All were clinically active at diagnosis, but only three
were so at commencement of dialysis and two on dialysis. The
complications on dialysis included infections, access problems and
thromboses. Conclusion: Most patients with lupus nephritis progressing
to end—stage renal failure have a histological pattern of WHO types III
and IV. Rate of progression of sclerosis is variable. Dialysis is well
tolerated and a successful form of therapy in patients with SLE.
Aluminium toxicity in hemodialysis patients: Preliminary results of the
Johannesburg study. Wittmer H, Seggie J, Meyers AM, Department of
Medicine, University of Witwatersrand, Johannesburg, South Africa.
In 1984, four patients died from aluminium encephalopathy. This
prompted a survey aimed at defining those patients at risk of developing
aluminium toxicity. This study involved 55 patients on chronic
hemodialysis (CHD) at the Johannesburg Hospital (JH). Serum
aluminium levels were estimated pre- and post-desferrioxamine (DFO).
These results were correlated with methyl di-phosphonate (MDP) bone
scans, EEG's and histomorphometry on five selected patients.
Aluminium levels of >200 pg/liter pre-DFO and an increase of
aluminium levels post-DFO infusion of >200 jsg/liter were considered
suggestive of aluminium toxicity. From the above criteria, 38% were
shown to be at risk of aluminium toxicity: 11% had high pre-DFO
aluminium levels, and a further 27% were unmasked by the DFO
infusion test. There was no significant correlation between the above
results and the MDP scans and EEG's. Histomorphometry conducted
on five bone biopsies revealed varying degrees of osteomalacia.
Aluminium staining of bone biopsies correlated with the DFO test in
that three patients positive on DFO testing had positive aluminium
staining, while in the remaining two patients with negative DFO tests
staining for aluminium in bone was negative. It is concluded that the
DFO infusion test is a reliable method of defining aluminium toxicity
and that 38% of the CHD population at the JH are so affected.
Nocardiosis in renal transplant recipients. Ruff P. Meyers AM, Botha
JR, Departments of Nephrology and Surgery, University of
Witwatersrand, Johannesburg, South Africa. Eighteen out of 572 renal
transplant recipients at the Johannesburg Hospital developed
Nocardiosis, in the period 1966 to 1984. It was therefore important to
ascertain the most important risk factors predisposing to Nocardiosis as
well as to assess the treatment regimens and final outcome of these
patients. Eighteen patients with Nocardiosis were statistically com-
pared to a control group of 45 uninfected transplant recipients by means
of the chi—square and Student's t-tests. The risk factors assessed were
age, sex, race, type of renal transplant, pretransplant nephrectomy or
splenectomy, blood transfusions, immunosuppressive regimens, treat-
ment of acute rejection episodes, concurrent infections and other
diseases, antibiotic usage, hemoglobin, white cell count, serum albu-
min, and creatinine. Statistically significant risk factors included treat-
ment of acute rejection episodes with high dose corticosteroids (P <
0.001) poor socioeconomic status (P < 0.05), pretransplant splenec-
tomy (P < 0.01) and hypoalbuminemia (P < 0.05). Six out of eight
patients (75%) receiving Sulphamethoxazole, Tnmethoprim and Mino-
cycline recovered, while six out of seven (86%) responded to a
combination of Sulphamethoxazole, Trimethoprim and Amikacin. A
total of 12 out of 18 (66.7%) patients with Nocardiosis recovered.
Conclusions: Renal transplant recipients treated for acute rejection
episodes with high dose steroids are at great risk for developing
Nocardiosis. Antibiotic regimens containing Amikacin as well as
Sulphamethoxazole plus Trimethoprim appear to be most effective.
Renal transplant recipients developing Nocardiosis appear to have a
fairly good prognosis.
Nephrotic syndrome of childhood at Baragwanath Hospital—a 5 year
analysis. Jacobs D, Kala U, Milner LS, Ninin D, Murray J, Department
of Paediatrics and Histopathology, University of Witwatersrand and
SAIMR, Johannesburg, South Africa. Renal biopsies of 67 children
ages 1 to 10 years with nephrotic syndrome (NS) were reviewed. The
mean age was 5.08 years with an overall male predominance. On light
microscopy: 20% had minimal change nephrotic syndrome (MLNS);
23% had glomerular sclerosis (GS); 21% had mesangioproliferative
nephritis (MP); 23% membranous nephropathy (MN); and 13% had a
miscellaneous (MISC) picture of which 30% had membranoprolifera-
tive; 40% focal segmental proliferative; 20% Henoch Schonlein Purpura
and 10% unclassifiable disease. Microscopic hematuria occurred in 76%
of MLNS and all the patients with GS, MP, MN and Misc. Hyperten-
sion occurred in 24% MLNS, 20% GS, 20% MP, 20% MN and 20% in
the Misc group. Tuberculosis was present in 38% GS, 28% MP, 7% MN
and absent in MLNS. A significant reduction in C3 levels occurred in
MN compared to MLNS. (0.96 0.25 vs. 1.47 0.55g/liter, P <0.01)
and MP (1.44 0.38, P < 0.001) and GS (1.62 0.57, P < 0.001).
Serum albumin was similar in all groups. Serum cholesterol was
significantly reduced in the MN compared to MP (10.2 1.86 vs. 13.89
5.8 mmollliter, P < 0.02). Serum AST and ALT in MN was
significantly elevated compared to other groups, suggesting subclinical
hepatitis. Eighty—seven percent of MN were positive for Hepatitis B
surface antigen, of which 100% were 'e' antigen positive. Response to
steroids or cytotoxics occurred in all cases of MLNS, 50% MP and 33%
GS. This study confirms the heterogeneity of NS in the childhood
population.
Interactions of DMSO and NSAID's in passive Heymann Nephritis
(PHN). Kaplan BS, Milner LS, Lotan D, Mills M, Goodyer PR, Fong
JSC, Department Nephrology, Montreal Childrens Hospital, McGill
University, Montreal, Canada. PHN is a model of membranous GN in
rats. Proteinuria in PHN is complement, but not neutrophil dependent.
A variety of NSAID's were used concurrently with DMSO to probe the
role of prostaglandin (Pg) in mediating the reduction of proteinuria by
DMSO in PHN. Rats with PHN were randomized into control (buffer)
or treatment groups. Treatment groups received DMSO alone or DMSO
+ NSAID or NSAID alone. After 14 days a significant reduction in
proteinuria occurred in rats treated with DMSO alone compared to
controls. (19.0 6 vs. 154 59 mg/day, P < 0.01) with reduced serum
triglyceride level (91.0 8.3vs. 162 17.6mg/dl, P <0.001). Serum C3
was similar between both groups with reduced renal C3 deposition in the
DMSO treated rats (0.4 vs. 1.8, P < 0.05). No differences in protein uria
occurred between rats treated with DMSO + Indo 1 mg/kg (161 27
mg/day) or Indo 1 mg/kg alone (184 65 mg/day) compared to controls
(154 59mg/day). No differences occurred in urinary protein excretion
between controls (268.8 44 mg/day) and rats receiving DMSO +
Meclofenemate (205.0 100.6 mg/day) or DMSO + ASA (161 33
mg/day). Rats treated with DMSO + Indo 5 mg/kg had a significant
reduction in proteinuria compared to controls (75.5 20 vs. 268.8 ±
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mg/day, P 0.05). Rats that received Indo 5 mg/kg alone had similar
protein excretion compared to controls (88 46 vs. 82 13 mg/day).
These studies suggest that PG stimulation by DMSO mediates the
reduction of proteinuria in PHN.
Dialyzer reuse (PR) in maintenance hemodialysis (MHI): Observations
over an 18 month period. Machado L, Meyers AM, Division of Nephro/-
ogy, Univ. of Witwatersrand & Johannesburg Hospital, Johannesburg,
South Africa. MUD costs R30,000/patient/year, much due to
disposables. Because of the recent financial crisis, DR was started so as
to minimize expenses but still maintain optimal patient care. Twen-
ty-one of a total of 78 patients on MUD are on DR. Three different
dialyzers were tested. After use dialyzers were cleaned with 10 vol%
peroxide, washed with N saline & stored at 4C with 4% formaldehyde
in situ. Before the next dialysis, the kidneys were rinsed with 1 liter N
saline and tested for formalin. Initially a semiautomatic procedure was
used which resulted in spillage, causing skin and mucous membrane
irritation in the DR team. A simple manual technique was chosen which
was found to be safe, efficient, and easy to perform. l'rc- and post-
dialysis ureas and creatinines were measured, and percent change
calculated with successful DRs. Problems such as febrile reactions,
pain, clotting, heparin requirement, leaks and bursts were monitored,
DR was 4 to 9 times (mean 6). Three patients could only achieve 2
DRs. Their Hbs 13.1 vs. 7.5 found in other patients. No pyrogenic
nor other untoward reactions have been noted in patients or staff. Delta
% pre- vs. post-ureas and creatinines remained stable from 1 to 9 DR,
and ultrafiltration characteristics did not change. Approximately
R60,000 was saved in one year which can trebled if DR could be
instituted for all patients. We conclude that short term studies have
shown this highly desirable procedure to he safe and effective. How-
ever, long term safety, immunological parameters and endotoxin levels
remain to be assessed.
Clinical and histological features of idiopathic diffuse mesangial prolif-
erative GN (DMP). Cohen JD, Goldberg B, Murray J, Ninin D, Mi/ne
FJ, Department of Medicine, Coronation and JG Str/jdom Hospitals
and University of the Witwatersrand and SAIMR, Johannesburg, South
Africa. Idiopathic DN4P is characterized histologically by diffuse
mesangial hypercellularity affecting most glomeruli, patent capillary
lumens, thin glomerular basement membranes (GMB), and the absence
of subepithelial or subendothelial deposits and/or reduplication of the
GBM. We studied 19 patients who fulfilled the criteria for DMP. All
patients had IF studies and 68% EM. Secondary causes were excluded
on clinical and serological testing. There were 12 males and seven
females, with a mean age of 27.4 years (13 to 52). Hypertension was
present in 31%, and microscopic hematuria in 89%. Proteinuria was
common (mean range 4. I 4.0g/day) and the mean serum creatinine at
presentation was 105.1 tmol/1iter 525. Only two patients had a raised
creatinine (>200 is/mol/liter). When patients were divided into those
without (9—group I) and with (10—group II) associated glomeruloscler-
osis (>10% glomeruli), there was no difference in age, sex, initial
creatinine, incidence of hypertension or haematuria between the two
groups. However, group I had a higher mean level of proteinuria (7.09
vs. 1.33 g/day, P = 0.006) and lower serum albumin (28.5 vs. 38.5
g/liter, P 0.039) than group II. Five of the nine from group I were
followed up, and three of the 10 from group 11. Proteinuria decreased to
0,16 g/day in group I, whereas the level had increased to 2.60 g/day in
group II. There was no difference in serum creatinine between the two
groups, but more from group II had hypertension and residual
hematuria.
Renal re-transplantation: The Johannesburg Hospital experience.
Veller MG, Botha JR, Margolius LP, Meyers AM, Thomson PD,
Myhurgh JA, Departments of Medicine and Surgery, Johannesburg
Hospital, Johannesburg, South Africa. Some patients lose their pri-
mary renal allograft. Most of these patients do better with a subsequent
transplant than on dialysis. Since 1968. 108 re-transplants were per-
formed at Johannesburg Hospital (14% of all kidney transplants). The
renal graft survival was analyzed using actuarial survival curves. The
overall graft survival for re-transplanted kidneys is 52.8% and 28.1% at
I and 10 years. These figures are no different from those for first
cadaver grafts. Compared to patients receiving blood transfusions prior
to first transplantation the result is significant. Factors correlating
poorly with graft survival included: age, type of donor for previous
transplant, cross—matching and HLA matching. Differences were noted
when the following were compared: previous chronic vs. acute rejec-
tion, male vs. female, less than 25% vs. more than 50% preformed
antibodies, Cyclosporine A vs. conventional immunosuppression, and
the whole group vs. analgesic nephropathy and diabetics (first men-
tioned have better graft survival). The results show that patients with
primary graft failure should be considered for re-transplantation, espe-
cially if not diabetic or have analgesic nephropathy, their previous
rejection episode occurred more than a year after implantation, they
have few preformed antibodies, and they will receive Cyclosporine A.
